Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3008402	s-meoh	— (—)	438	538	100.00%	Distribution not available
3008402	s-meoh	mmol/l (mmol/l)	42	43	86.05%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Convulsions, not elsewhere classified

14.83

101.71

1.4

1.3

—

mmol/l

—

Other antidepressants

195

147

6.94

93.00

1.5

1.1

1.02

—

mmol/l

—

Recurrent or chronic depression

19.61

67.18

1.2

1.1

—

mmol/l

—

Nonorganic sleeping disorders, excluding more controls

26.01

63.42

1.2

1.0

—

mmol/l

—

Bleeding

139

216

4.69

53.93

1.2

1.3

—

1.03

mmol/l

—

Mental and behavioural disorders due to opioids

33.70

51.36

1.2

1.6

—

Traumatic subdural haemorrhage

17.21

47.98

1.1

1.2

—

mmol/l

—

Superficial injury of head

9.16

42.96

1.2

1.6

—

mmol/l

—

Non-selective monoamine reuptake inhibitors

7.51

42.42

1.1

—

mmol/l

—

Persistent mood disorders

9.34

33.54

1.3

1.1

—

mmol/l

—

Fracture of skull and facial bones

7.24

30.04

1.2

1.3

—

mmol/l

—

Heart failure, not strict

102

199

3.54

27.34

1.1

1.2

—

1.24

mmol/l

—

Erysipelas

172

3.93

25.14

1.2

—

0.98

mmol/l

—

Maltreatment syndromes

12.76

24.61

1.2

1.3

—

mmol/l

—

Viral hepatitis, IBD co-morbidity

41.81

23.62

1.2

1.0

—

mmol/l

—

Infections of the skin and subcutaneous tissue

272

3.26

23.51

1.2

1.3

—

0.96

mmol/l

—

Other and unspecified mood [affective] disorders

17.37

22.91

1.6

1.0

—

Other maltreatment syndromes

15.65

19.38

1.1

1.5

—

Hyperkinetic disorders, excluding more controls

44.93

18.93

2.1

1.0

—

Infections, IBD-co-morbidities

8.84

15.83

1.1

—

mmol/l

—

Hernia of abdominal wall, postoperative

6.43

15.35

1.2

1.1

—

Complications of medical and surgical care

277

2.64

14.01

1.5

1.2

—

1.00

mmol/l

—

Other and unspecified injuries of head

10.06

13.13

1.1

1.5

—

Injury of other and unspecified intrathoracic organs

7.25

12.27

1.3

—

mmol/l

—

Gastro-oesophageal reflux disease

246

2.56

12.01

1.4

1.2

—

1.02

mmol/l

—

Traumatic subarachnoid haemorrhage

23.10

11.58

1.1

1.3

—

mmol/l

—

Non-invasive ventilation

17.77

11.17

1.1

—

Cardiac arrest

8.11

10.50

1.0

1.3

—

mmol/l

—

Speech and linguistic disorders, excluding more controls

26.46

10.40

1.0

—

Other symptoms and signs involving general sensations and perceptions

18.92

10.26

1.1

—

Psychotic depression

23.44

10.23

1.2

1.0

—

mmol/l

—

Monoamine oxidase A inhibitors

6.83

9.72

1.0

—

mmol/l

—

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

8.49

9.19

1.1

2.2

—

Other heart diseases, wide

289

2.04

8.92

1.1

1.3

—

1.03

mmol/l

—

Obesity and other hyperalimentation

265

2.32

8.80

1.1

1.3

—

0.96

mmol/l

—

Early onset COPD, excluding more controls

4.00

8.76

1.0

1.2

—

mmol/l

—

Focal brain injury

8.49

8.46

1.0

1.2

—

mmol/l

—

Neuromuscular dysfunction of bladder

5.17

8.40

2.6

1.1

—

mmol/l

—

Obesity

265

2.28

8.37

1.1

1.3

—

0.96

mmol/l

—

Other degenerative diseases of the nervous system

4.74

8.20

1.5

1.1

—

mmol/l

—

Hepatic failure, not elsewhere classified

7.92

7.99

1.0

1.5

—

mmol/l

—

Toxic effect of organic solvents

+∞

7.35

3.3

0.0

—

mmol/l

—

Ascites

6.90

7.15

1.2

1.3

—

mmol/l

—

Dissociative [conversion] disorders

13.83

6.89

4.3

1.6

—

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

6.81

1.1

—

mmol/l

—

Dissocial personality disorder

16.92

6.76

1.2

1.0

—

mmol/l

—

Any dementia, excluding more controls

4.31

6.45

1.1

1.0

—

mmol/l

—

Alcohol abuse counselling and surveillance

14.49

6.41

2.0

1.0

—

Special screening examination for other diseases and disorders

5.25

5.52

1.1

—

Complications of procedures, not elsewhere classified

304

1.88

5.42

1.5

1.2

—

0.98

mmol/l

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

314

1.78

5.40

1.5

1.2

—

0.96

mmol/l

—

Folate deficiency anaemia

+∞

5.22

1.0

0.0

—

mmol/l

—

Agoraphobia

13.40

5.08

1.0

1.8

—

Diffuse brain injury

13.39

5.08

1.1

1.3

—

mmol/l

—

Cirrhosis of liver, NAS

5.02

4.78

1.0

1.1

—

mmol/l

—

Parodontitis and operation codes

332

1.73

4.67

1.1

1.2

—

1.03

mmol/l

—

Constipation

270

1.78

4.55

1.4

1.3

—

1.00

mmol/l

—

Symptoms and signs concerning food and fluid intake

4.40

4.55

1.0

1.3

—

Complications of internal orthopaedic prosthetic devices, implants and grafts

2.97

4.54

1.2

—

mmol/l

—

Implicit fungal Sepsis

10.06

4.52

1.1

1.3

—

Parodontitis

334

1.70

4.51

1.1

1.2

—

1.03

mmol/l

—

Parodontitis or operation codes

334

1.70

4.50

1.1

1.2

—

1.03

mmol/l

—

Special screening examination for infectious and parasitic diseases

2.79

4.41

1.0

1.1

—

Vocal cord dysfunction

13.01

4.38

1.1

1.2

—

mmol/l

—

Open wound of abdomen, lower back and pelvis

7.55

4.36

1.3

—

mmol/l

—

Fungal Sepsis

8.93

4.28

1.1

1.2

—

Other and unspecified intracranial injuries

11.73

4.28

1.3

1.8

—

mmol/l

—

Other diseases of pancreas

4.36

4.09

1.3

1.1

—

mmol/l

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

3.76

4.08

1.0

1.2

—

Chronic periodontitis, including avohilmo

336

1.65

4.01

1.1

1.2

—

1.03

mmol/l

—

Other neurological diseases

241

1.80

3.97

1.1

1.2

—

1.00

mmol/l

—

Later onset COPD, excluding more controls

3.41

3.91

1.1

—

Hypothyroidism, drug reimbursement

8.17

3.83

1.0

—

12.08

3.77

1.2

1.0

—

Conduct disorder

12.07

3.76

4.8

1.0

—

Fibrosis and cirrhosis of liver

3.86

3.52

1.0

1.3

—

mmol/l

—

Neuralgia and neuritis, unspecified

5.02

3.37

1.3

1.4

—

Unspecified jaundice

7.02

3.36

1.0

1.5

—

mmol/l

—

Intestinal adhesions without obstruction

3.71

3.35

1.1

1.3

—

Other diseases of intestine

3.08

1.5

1.3

—

Prurigo nodularis

10.05

2.98

1.0

2.0

—

mmol/l

—

Moderate visual impairment, binocular

10.04

2.98

1.4

1.0

—

mmol/l

—

Allergic purpura

6.69

2.87

2.7

1.1

—

Mumps

6.03

2.70

1.0

1.5

—

Pneumonia derived septicemia

6.02

2.70

1.0

1.7

—

Residual foreign body in soft tissue

4.22

2.68

1.1

1.4

—

ILD, hospital admission 2, with pulmonary infections

3.76

2.67

1.1

1.3

—

Injury of eye and orbit

2.79

2.64

1.2

—

Malignant neoplasm of testis, excluding all cancers (controls excluding all cancers)

7.18

2.55

1.0

1.3

—

mmol/l

—

Myalgia

2.35

2.55

1.1

1.3

—

Complications of other internal prosthetic devices, implants and grafts

7.16

2.55

1.2

1.0

—

mmol/l

—

Paralytic ileus

5.47

2.54

1.2

1.6

—

Pneumonia due to Streptococcus pneumoniae

4.39

2.47

1.0

1.5

—

Other inflammatory liver diseases

3.64

2.36

1.3

1.4

—

mmol/l

—

Benign neoplasm of meninges

3.64

2.36

1.0

1.1

—

mmol/l

—

Oxicams

2.30

1.1

1.0

—

mmol/l

—

Respiratory insufficiency

3.89

2.24

1.0

1.4

—

mmol/l

—

Other intervertebral disc disorders

260

1.48

2.22

1.1

1.2

—

1.00

mmol/l

—

Generalized epilepsy, strict definition

5.58

2.21

2.0

1.7

—

Schizotypal disorder

5.58

2.21

1.0

1.6

—

Burns and corrosions confined to eye and internal organs

5.58

2.21

1.4

1.0

—

Malignant neoplasm of oral cavity, excluding all cancers (controls excluding all cancers)

4.30

2.15

1.0

1.1

—

Diseases of arteries, arterioles and capillaries

203

1.58

2.10

1.0

1.2

—

1.00

mmol/l

—

Lichen simplex chronicus and prurigo

3.21

2.09

1.0

1.3

—

mmol/l

—

Alzheimer disease, excluding more controls

5.56

2.06

1.2

1.0

—

Benign neoplasm: Cerebral meninges

3.50

2.05

1.0

1.2

—

mmol/l

—

Lumbar disc prolapse

250

1.53

2.04

1.1

1.2

—

1.00

mmol/l

—

Pneumococcal septicemia

4.56

1.94

1.0

1.3

—

Injury of nerves at wrist and hand level

4.56

1.94

1.0

1.2

—

mmol/l

—

Myocarditis

3.76

1.93

1.2

1.3

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

239

1.55

1.89

1.1

1.2

—

1.00

mmol/l

—

Other blood glucose lowering drugs, excl. Insulins

2.39

1.85

1.1

1.2

—

mmol/l

—

Benign neoplasm of colon, rectum, anus and anal canal

213

1.57

1.83

1.2

—

1.00

mmol/l

—

Olecranon bursitis

3.05

1.80

1.1

1.5

—

Spondylopathies

237

1.44

1.74

1.1

1.2

—

1.00

mmol/l

—

Osteoporosis with pathological fracture (FG)

3.85

1.71

1.0

1.4

—

mmol/l

—

Other arrhythmias

209

1.50

1.67

1.1

1.3

—

1.03

mmol/l

—

Benign neoplasm: Colon

195

1.56

1.55

1.2

—

1.00

mmol/l

—

Trigger finger

2.27

1.53

1.0

1.4

—

mmol/l

—

Adrenocortical insufficiency

3.34

1.52

1.0

1.4

—

mmol/l

—

Enlarged lymph nodes

2.43

1.47

1.4

1.2

—

mmol/l

—

Other bursopathies

2.22

1.46

1.2

1.4

—

mmol/l

—

Adhesive capsulitis of shoulder

2.12

1.44

1.2

1.3

—

Abnormal blood-pressure reading, without diagnosis

3.13

1.44

1.0

1.3

—

Unknown and unspecified causes of morbidity

2.73

1.43

1.3

—

Vascular disorders of the intestines

2.94

1.36

1.2

1.4

—

Sulfonylureas

1.73

1.32

1.0

1.2

—

mmol/l

—

Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)

2.35

1.29

1.0

1.1

—

mmol/l

—

Trochanteric bursitis

2.22

1.24

1.0

1.3

—

Synovial cyst of popliteal space [Baker]

2.31

1.18

1.0

1.3

—

mmol/l

—

Other retinal disorders

205

1.41

1.15

1.0

1.3

—

1.00

mmol/l

—

Oral corticosteroids

358

1.27

1.15

1.1

1.3

—

0.96

mmol/l

—

Dislocation, sprain and strain of joints and ligaments of elbow

2.38

1.09

1.0

1.1

—

Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)

2.18

1.07

1.0

1.1

—

mmol/l

—

Plantar fascial fibromatosis

2.12

1.05

1.3

—

mmol/l

—

Benign neoplasm: Caecum

0.00

0.97

0.0

1.1

—

Injury of muscle and tendon at wrist and hand level

1.85

0.96

1.0

1.2

—

Other diseases of hard tissues of teeth

231

1.32

0.93

1.1

1.2

—

1.24

mmol/l

—

Female infertility

0.51

0.86

1.0

—

mmol/l

—

Nummular dermatitis

1.94

0.84

1.0

1.2

—

mmol/l

—

Other disorders of ear

329

0.77

0.84

1.1

1.3

—

0.96

mmol/l

—

Chronic laryngitis and laryngotracheitis

1.74

0.82

1.1

—

Benign neoplasm: Ascending colon

1.82

0.79

1.2

1.1

—

Benign neoplasm of brain and other parts of central nervous system

2.09

0.74

1.0

1.1

—

mmol/l

—

Malignant neoplasm of eye, brain and central nervous system, excluding all cancers (controls excluding all cancers)

2.08

0.74

1.0

1.1

—

mmol/l

—

Fissure and fistula of anal and rectal regions

0.55

0.67

1.2

—

mmol/l

—

Disorders of choroid and retina

266

1.23

0.64

1.0

1.2

—

1.03

mmol/l

—

Benign neoplasm: Transverse colon

1.73

0.64

1.4

1.1

—

mmol/l

—

Female infertility, cervigal, vaginal, other or unspecified origin

0.57

0.63

1.0

—

mmol/l

—

Inflammatory bowel disease treatment related agents

375

1.17

0.61

1.1

1.3

—

0.96

mmol/l

—

Inflammatory disease of cervix uteri

0.00

0.60

0.0

1.3

—

Autoimmune diseases related-to ILD

390

1.20

0.60

1.2

—

1.03

mmol/l

—

Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)

0.00

0.59

0.0

1.1

—

Gingivitis and periodontal diseases

237

1.20

0.59

1.3

1.2

—

1.24

mmol/l

—

Female infertility, associated with anovulation

0.00

0.58

0.0

1.0

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

333

1.17

0.54

1.1

1.2

—

1.03

mmol/l

—

Cholecystitis

1.46

0.50

1.0

1.1

—

mmol/l

—

Artificial joint operation, meniscal resection

329

0.85

0.45

1.1

1.2

—

1.03

mmol/l

—

Metatarsalgia

1.52

0.41

1.0

1.3

—

Other articular cartilage disorders

0.00

0.41

0.0

1.5

—

Other specified and unspecified retinal disorders

0.00

0.41

0.0

1.1

—

Golimumab

0.00

0.41

0.0

1.4

—

Melanocytic naevi of lower limb, including hip

0.00

0.41

0.0

1.4

—

Melanocytic naevi of lower limb, including hip

0.00

0.41

0.0

1.1

—

Malignant neoplasm of ovary

0.00

0.41

0.0

1.4

—

Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)

0.00

0.41

0.0

1.1

—

Benign neoplasm: Skin of trunk

0.00

0.41

0.0

1.2

—

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

0.00

0.40

0.0

1.2

—

Other noninflammatory disorders of cervix uteri

0.00

0.40

0.0

1.1

—

Other enthesopathy of foot (+metatarsalgia)

1.43

0.39

1.0

1.3

—

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

0.00

0.39

0.0

1.4

—

Other disorders of bladder

1.39

0.38

1.2

1.1

—

Fenamates

1.50

0.37

1.8

1.0

—

Gonarthrosis [arthrosis of knee](FG)

237

1.14

0.34

1.2

—

1.24

mmol/l

—

Coxarthrosis [arthrosis of hip](FG)

178

1.18

0.32

1.2

—

1.24

mmol/l

—

Other menopausal disorders

0.70

0.32

1.0

1.1

—

mmol/l

—

Endometriosis of ovary

1.32

0.30

1.1

—

mmol/l

—

Polyp of the female genital tract

0.73

0.30

1.0

—

Benign neoplasm: Rectum

1.27

0.30

1.1

—

Benign neoplasm: Rectum, anus and anal canal

1.21

0.26

1.3

1.1

—

Dental caries 2, only avohilmo

327

0.89

0.25

1.0

1.3

—

0.96

mmol/l

—

Hypertrichosis

0.00

0.21

0.0

1.6

—

Hyperaldosteronism

0.00

0.21

0.0

1.3

—

Hodgkin lymphoma

0.00

0.21

0.0

1.3

—

Correction of physiology of bite - very demanding therapy visit

0.00

0.21

0.0

1.6

—

Systemic lupus erythematosus, unspecified

0.00

0.21

0.0

1.5

—

Nontoxic diffuse goitre

0.00

0.21

0.0

1.5

—

Benign neoplasm: Conjunctiva

0.00

0.21

0.0

1.1

—

Sixth [abducent] nerve palsy

0.00

0.21

0.0

1.7

—

SLE, ICD10

0.00

0.21

0.0

1.5

—

SLE, strict definition

0.00

0.21

0.0

1.5

—

Melanoma in situ

0.00

0.21

0.0

1.2

—

Systemic lupus erythematosus

0.00

0.21

0.0

1.5

—

Subacute thyroiditis

0.00

0.21

0.0

1.5

—

Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)

0.00

0.21

0.0

1.2

—

Diffuse large B-cell lymphoma, helper endpoint

0.00

0.21

0.0

1.2

—

Multiple myeloma and malignant plasma cell neoplasms

0.00

0.21

0.0

1.2

—

Multiple myeloma, excluding all cancers (controls excluding all cancers)

0.00

0.21

0.0

1.2

—

Other benign neoplasms of uterus

0.00

0.21

0.0

1.5

—

Erosion and ectropion of cervix uteri

0.00

0.21

0.0

1.0

—

Serous carcinoma of ovary

0.00

0.21

0.0

1.4

—

Infections of breast associated with childbirth

0.00

0.21

0.0

1.5

—

Medial epicondylitis

0.00

0.21

0.0

1.5

—

Female infertility, tubal origin

0.00

0.20

0.0

1.1

—

Finngen Rheumatological endpoints

322

1.08

0.20

1.2

1.3

—

1.03

mmol/l

—

Dental caries 2

335

0.91

0.18

1.0

1.3

—

0.96

mmol/l

—

Disorders of sclera, cornea, iris and ciliary body

252

1.11

0.17

1.5

1.3

—

0.96

mmol/l

—

Oter anti-inflammatory and antirheumatic agents, non-steroids

1.17

0.17

1.1

1.0

—

Gonarthrosis,primary

278

1.06

0.12

1.2

—

1.24

mmol/l

—

Non-rheumatic valve diseases

138

0.90

0.11

1.2

1.3

—

1.00

mmol/l

—

Valvular heart disease excluding rheumatic fever

138

0.90

0.11

1.2

1.3

—

1.00

mmol/l

—

Postmenopausal bleeding

1.17

0.10

1.0

1.1

—

mmol/l

—

Lateral epicondylitis

1.11

0.09

1.2

1.3

—

Dental caries 2 and operation codes

326

0.95

0.08

1.0

1.3

—

0.96

mmol/l

—

Other noninflammatory disorders of uterus, except cervix

0.78

0.08

1.0

1.1

—

mmol/l

—

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

0.79

0.08

1.4

1.0

—

mmol/l

—

Pain and other conditions associated with female genital organs and menstrual cycle

1.07

0.08

2.7

1.0

—

Haemorrhoids and perianal venous thrombosis

1.12

0.07

1.1

1.2

—

mmol/l

—

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

1.03

0.07

1.3

1.2

—

mmol/l

—

Dysplasia of cervi uteri

0.82

0.07

2.1

1.0

—

Nasal polyp

0.84

0.07

1.0

1.2

—

mmol/l

—

Disorders of eyelid, lacrimal system and orbit

304

1.03

0.04

1.0

1.3

—

1.00

mmol/l

—

Female genital prolapse

1.06

0.00

1.1

1.0

—

Arthropathy in ulcerative colitis

0.00

0.0

1.2

—

Autoimmune thyroiditis

0.00

0.0

1.1

—

Cytomegaloviral disease

0.00

0.0

1.6

—

Other acute disseminated demyelination

0.00

0.0

1.2

—

Other specified congenital malformation syndromes affecting multiple systems

0.00

0.0

1.2

—

Primary biliary cholangitis (PBC)

0.00

0.0

1.6

—

Graves ophthalmopathy, strict

0.00

0.0

1.8

—

Benign neoplasm: Conjunctiva

0.00

0.0

2.0

—

Other specified/unspecified deforming dorsopathies

0.00

0.0

1.7

—

Benign neoplasm: Lip

0.00

0.0

1.0

—

Benign neoplasm: Skin of ear and external auricular canal

0.00

0.0

1.0

—

Congenital malformations of breast

0.00

0.0

1.2

—

Congenital iodine-deficiency syndrome/hypothyroidism

0.00

0.0

1.7

—

Bruxism

0.00

0.0

1.8

—

Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)

0.93

0.00

1.0

1.1

—

Thyroiditis, unspecified

0.00

0.0

2.0

—

Polycythaemia vera

0.00

0.0

1.3

—

Other benign neoplasm of uterus: Other parts/unspecified

0.00

0.0

1.0

—

CR(E)ST syndrome

0.00

0.0

2.0

—

Adenocarcinoma and ductal carcinoma of pancreas, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.4

—

Malignant neoplasm of other and unspecified female genital organs

0.00

0.0

1.0

—

Malignant neoplasm of other and unspecified female genital organs, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.0

—

Allergic contact dermatitis due to drugs in contact with skin

0.00

0.0

1.2

—

Chronic Coagulation defects

0.00

0.0

1.7

—

Iliotibial band syndrome

0.00

0.0

2.0

—

Myeloid leukaemia

0.00

0.0

1.3

—

Background retinopathy and retinal vascular changes

0.00

0.0

1.5

—

Viral infections of central nervous system, not elsewhere classified/unspecified

0.00

0.0

2.0

—

Carcinoma in situ of cervix uteri, endocervix

0.00

0.0

1.8

—

Idiopathic urticaria

0.00

0.0

1.6

—

Prolapse and hernia of ovary and fallopian tube

0.00

0.0

1.0

—

Benign neoplasm: Vagina

0.00

0.0

2.0

—

Fistulae involving female genital tract

0.00

0.0

1.0

—

Melanocytic naevi of scalp and neck

0.00

0.0

2.0

—

Family history of other conditions

0.00

0.0

1.0

—

Other retinal artery occlusion

0.00

0.0

1.0

—

Endometriosis of intestine

0.00

0.0

1.0

—

Disorders of globe

0.00

0.0

1.3

—

Galactorrhea

0.00

0.0

2.2

—

Sexual dysfunction

0.00

0.0

1.0

—

Carcinoma in situ of other and unspecified genital organs

0.00

0.0

2.0

—

Carcinoma in situ of other and unspecified genital organs

0.00

0.0

1.0

—

Other benign neoplasms of uterus

0.00

0.0

1.0

—

Benign neoplasm: Vagina

0.00

0.0

1.2

—

Carcinoma in situ of cervix uteri, endocervix

0.00

0.0

1.1

—

Benign neoplasm: Sigmoid colon

1.00

0.00

1.2

1.1

—

Melanocytic naevi of scalp and neck

0.00

0.0

1.5

—

Problems related to social environment

0.00

0.0

1.9

—

Parkinson's disease, strict definition, excluding more controls

0.00

0.0

1.0

—

Crushing injury of wrist and hand

0.00

0.0

1.4

—

Epiphora

0.00

0.0

1.1

—

Other abnormal immunological findings in serum

0.00

0.0

1.2

—

Placental disorders

0.00

0.0

1.2

—

Hydatidiform mole

0.00

0.0

2.2

—

Torsion of ovary, ovarian pedicle and fallopian tube

0.00

0.0

1.0

—

Hereditary retinal dystrophy

0.00

0.0

1.0

—

Use of teriflunomide

0.00

0.0

1.2

—

Serous carcinoma of ovary, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.0

—

Non-small cell lung cancer, squamous, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.3

—

Premenstrual syndrome

0.00

0.0

1.0

—

Use of fingolimod

0.00

0.0

1.2

—

Complications associated with artificial fertilization

0.00

0.0

1.0

—

Migraine without aura, drug-induced

0.00

0.0

1.2

—

Hirsutism in women

0.00

0.0

1.7

—

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

0.00

0.0

1.2

—

Venous complications and haemorrhoids in pregnancy

0.00

0.0

1.7

—

Short Achilles tendon (acquired)

0.00

0.0

1.6

—

Other disorders of breast and lactation associated with childbirth

0.00

0.0

1.2

—

Habitual aborter

0.00

0.0

1.0

—

Other and unspecified nail disorders

0.00

0.0

1.7

—

Lung cancer and mesothelioma

0.99

0.00

1.4

1.2

—

mmol/l

—

Benign neoplasm: Lip

0.00

0.0

1.8

—

Granulomatous disorders of skin and subcutaneous tissue

0.00

0.0

1.0

—

Graves ophthalmopathy

0.00

0.0

1.7

—

Other and unspecified acne

0.00

0.0

1.0

—

Other assisted single delivery

0.00

0.0

1.7

—

Oral lichen ruber planus

0.00

0.0

1.6

—

Rare circulating lymphoid malignancy, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.2

—

Pneumonia due to other infectious organisms, not elsewhere classified

0.00

0.0

2.1

—

Other melanin hyperpigmentation

0.00

0.0

1.0

—

Viral agents as the cause of diseases classified to other chapters

0.00

0.0

1.2

—

Disorders of lacrimal system and orbit in diseases classified elsewhere

0.00

0.0

1.8

—

Other lesions of median nerve

0.00

0.0

1.0

—

Other overlap syndromes

0.00

0.0

1.2

—

Urethritis and urethral syndrome

0.00

0.0

1.0

—

Convergence insufficiency and excess

0.00

0.0

1.2

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Methanol [Moles/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS